Teresa Brophy Bair, Chief Legal Officer at Kura Oncology, Inc. (KURA), sold 17,608 shares at $11.18 ($197K) on 2025-11-14, disclosed to the SEC on 2025-11-14.
Scheduled sale ($197k) by Chief Legal Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.18 | 8,804 | $98K | 50.0% |
| 2 | $11.18 | 8,804 | $98K | 50.0% |
| Total | $11.18 avg | 17,608 | $197K | 100% |
| Filing → |
| KURA | SELL | 2026-05-20 | $21K | — | Filing → |
| KURA | SELL | 2026-01-27 | $95K | — | Filing → |
| KURA | SELL | 2025-09-29 | $157K | — | Filing → |